Aliskiren and Furosemide Interaction

Drug interaction information between Aliskiren and Furosemide.

Aliskiren and Furosemide have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Aliskiren and Furosemide. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Aliskiren

Direct Renin Inhibitor

Drug B

Furosemide

Loop Diuretic

How They Interact

Aliskiren reduces the amount of furosemide that gets into your body, which can make the water pill less effective at removing fluid.

FDA Label Information

Furosemide: Oral coadministration of aliskiren and furosemide reduced exposure to furosemide. Monitor diuretic effects when furosemide is coadministered with aliskiren.

Frequently Asked Questions

What SPL severity band is on file for Aliskiren + Furosemide?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Furosemide has 36 labeled pairs on file vs Aliskiren's 28. In the minor band specifically: Aliskiren has 3 (also Potassium Chloride, Potassium Citrate); Furosemide has 29 (also Methotrexate, Norepinephrine, Ethacrynic Acid, Indomethacin).

What mechanism field is on file for Aliskiren and Furosemide?

Aliskiren reduces the amount of furosemide that gets into your body, which can make the water pill less effective at removing fluid.

Aliskiren carries more major-labeled pairs than Furosemide

SPL source-record counts only. This page's band is minor · classes on file: Aliskiren (Direct Renin Inhibitor); Furosemide (Loop Diuretic).

Aliskiren has 22 major-labeled pairs vs Furosemide's 3. This page itself is in the minor band, not the major band.

Aliskiren

22 major · 3 moderate · 3 minor · 28 total

Furosemide

3 major · 4 moderate · 29 minor · 36 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.